These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3509283)

  • 1. Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.
    Chakraborty BS; Sardessai MS; Jaworski TJ; Midha KK; Hawes EM
    Pharm Res; 1987 Jun; 4(3):207-13. PubMed ID: 3509283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for psychotropic drugs. III: Synthesis and properties of haptens for trifluoperazine and fluphenazine.
    Hawes EM; Shetty HU; Cooper JK; Rauw G; McKay G; Midha KK
    J Pharm Sci; 1984 Feb; 73(2):247-50. PubMed ID: 6707894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM; Mailman RB; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for psychotropic drugs I: synthesis and properties of haptens for chlorpromazine.
    Hubbard JW; Midha KK; McGilveray IJ; Cooper JK
    J Pharm Sci; 1978 Nov; 67(11):1563-71. PubMed ID: 712593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for psychotropic drugs II: synthesis and properties of haptens for tricyclic antidepressants.
    Hubbard JW; Midha KK; Cooper JK; Charette C
    J Pharm Sci; 1978 Nov; 67(11):1571-8. PubMed ID: 712594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.
    Lin G; Hawes EM; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 1993 Oct; 23(10):1059-74. PubMed ID: 8259689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lactams as in vitro metabolites of piperidine-type phenothiazine antipsychotic drugs.
    Lin G; Chu KW; Damani LA; Hawes EM; Midha KK
    J Pharm Biomed Anal; 1996 Apr; 14(6):727-38. PubMed ID: 8807548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVA-induced genetic effects of thioridazine, mesoridazine and sulforidazine: an in vitro study.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Panday IR
    Z Naturforsch C J Biosci; 1990 Jun; 45(6):638-44. PubMed ID: 2205215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic method.
    Chakraborty BS; Hawes EM; Midha KK
    Ther Drug Monit; 1987 Dec; 9(4):464-71. PubMed ID: 3424415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
    Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
    J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-oxidation of thioridazine to psychoactive metabolites: an oral dose-proportionality study in healthy volunteers.
    Chakraborty BS; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Midha KK; Choc MG; Robinson WT
    Drug Metabol Drug Interact; 1988; 6(3-4):425-37. PubMed ID: 3271648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a radioimmunoassay procedure for sulforidazine and its comparison with a high-performance liquid chromatographic method.
    Chakraborty BS; Hawes EM; Midha KK
    Ther Drug Monit; 1988; 10(2):205-14. PubMed ID: 3381240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):117-25. PubMed ID: 2746491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined ultraviolet-fluorescence detection in high-pressure liquid chromatography of pharmaceuticals.
    Lindner W; Frei RW; Santi W
    J Chromatogr; 1975 Sep; 111(2):365-71. PubMed ID: 1159014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of piperidine-type phenothiazine antipsychotic agents. III. Mesoridazine in dog, human and rat.
    Lin G; Hawes EM; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 1993 Jan; 23(1):37-52. PubMed ID: 8097900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity.
    Llerena A; Berecz R; de la Rubia A; Norberto MJ; Benítez J
    Ther Drug Monit; 2000 Aug; 22(4):397-401. PubMed ID: 10942178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.